Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 183

1.

Tumor Suppressor Down-Regulation Promotes Hepatocyte Proliferation: A New GANKster on the Block.

Pimienta M, Seki E.

Cell Mol Gastroenterol Hepatol. 2018 Jul 7;6(3):345-346. doi: 10.1016/j.jcmgh.2018.06.003. eCollection 2018. No abstract available.

2.

MicroRNA-942 mediates hepatic stellate cell activation by regulating BAMBI expression in human liver fibrosis.

Tao L, Xue D, Shen D, Ma W, Zhang J, Wang X, Zhang W, Wu L, Pan K, Yang Y, Nwosu ZC, Dooley S, Seki E, Liu C.

Arch Toxicol. 2018 Sep;92(9):2935-2946. doi: 10.1007/s00204-018-2278-9. Epub 2018 Aug 10.

PMID:
30097701
3.

Interventional Potential of Recombinant Feline Hepatocyte Growth Factor in a Mouse Model of Non-alcoholic Steatohepatitis.

Yang YM, Fukui M, Wang Z, Miao F, Karriker MJ, Seki E.

Front Endocrinol (Lausanne). 2018 Jul 23;9:378. doi: 10.3389/fendo.2018.00378. eCollection 2018.

4.

New mitochondrial DNA synthesis enables NLRP3 inflammasome activation.

Zhong Z, Liang S, Sanchez-Lopez E, He F, Shalapour S, Lin XJ, Wong J, Ding S, Seki E, Schnabl B, Hevener AL, Greenberg HB, Kisseleva T, Karin M.

Nature. 2018 Aug;560(7717):198-203. doi: 10.1038/s41586-018-0372-z. Epub 2018 Jul 25.

PMID:
30046112
5.

Chemokines and Chemokine Receptors in the Development of NAFLD.

Roh YS, Seki E.

Adv Exp Med Biol. 2018;1061:45-53. doi: 10.1007/978-981-10-8684-7_4.

PMID:
29956205
6.

Liver Cancer Initiation Requires p53 Inhibition by CD44-Enhanced Growth Factor Signaling.

Dhar D, Antonucci L, Nakagawa H, Kim JY, Glitzner E, Caruso S, Shalapour S, Yang L, Valasek MA, Lee S, Minnich K, Seki E, Tuckermann J, Sibilia M, Zucman-Rossi J, Karin M.

Cancer Cell. 2018 Jun 11;33(6):1061-1077.e6. doi: 10.1016/j.ccell.2018.05.003.

PMID:
29894692
7.

Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer.

Liu T, Yang H, Fan W, Tu J, Li TWH, Wang J, Shen H, Yang J, Xiong T, Steggerda J, Liu Z, Noureddin M, Maldonado SS, Annamalai A, Seki E, Mato JM, Lu SC.

Gastroenterology. 2018 Aug;155(2):557-571.e14. doi: 10.1053/j.gastro.2018.04.032. Epub 2018 May 5.

PMID:
29733835
8.

Astrocyte elevated gene-1 (AEG-1): a new potential therapeutic target for the treatment of nonalcoholic steatohepatitis (NASH).

Wang Q, Seki E.

Hepatobiliary Surg Nutr. 2018 Feb;7(1):44-47. doi: 10.21037/hbsn.2017.11.04. No abstract available.

9.

Cell-Free Protein Synthesis for Multiple Site-Specific Incorporation of Noncanonical Amino Acids Using Cell Extracts from RF-1 Deletion E. coli Strains.

Seki E, Yanagisawa T, Yokoyama S.

Methods Mol Biol. 2018;1728:49-65. doi: 10.1007/978-1-4939-7574-7_3.

PMID:
29404990
10.
11.

[Successful Early Surgical Treatment for Infected Traumatic Pulmonary Pseudocyst].

Goto M, Aoyama K, Seki E, Shimotakahara A, Watarai H, Hirose T, Shimoda M, Haga T.

Kyobu Geka. 2017 Dec;70(13):1075-1078. Japanese.

PMID:
29249785
12.

S-adenosylmethionine and methylthioadenosine inhibit cancer metastasis by targeting microRNA 34a/b-methionine adenosyltransferase 2A/2B axis.

Tomasi ML, Cossu C, Spissu Y, Floris A, Ryoo M, Iglesias-Ara A, Wang Q, Pandol SJ, Bhowmick NA, Seki E, Posadas EM, Lu SC.

Oncotarget. 2017 Aug 12;8(45):78851-78869. doi: 10.18632/oncotarget.20234. eCollection 2017 Oct 3.

13.

The contribution of toll-like receptor signaling to the development of liver fibrosis and cancer in hepatocyte-specific TAK1-deleted mice.

Song IJ, Yang YM, Inokuchi-Shimizu S, Roh YS, Yang L, Seki E.

Int J Cancer. 2018 Jan 1;142(1):81-91. doi: 10.1002/ijc.31029. Epub 2017 Sep 23.

14.

TRIF Differentially Regulates Hepatic Steatosis and Inflammation/Fibrosis in Mice.

Yang L, Miura K, Zhang B, Matsushita H, Yang YM, Liang S, Song J, Roh YS, Seki E.

Cell Mol Gastroenterol Hepatol. 2017 Jan 17;3(3):469-483. doi: 10.1016/j.jcmgh.2016.12.004. eCollection 2017 May.

15.

Corrigendum to "Multiple inhibitory factor removal from an Escherichia coli cell extract improves cell-free protein synthesis" [J Biosci Bioeng 108 (2009) 30-35].

Seki E, Matsuda N, Kigawa T.

J Biosci Bioeng. 2017 Jan;123(1):139. doi: 10.1016/j.jbiosc.2016.10.001. Epub 2016 Oct 27. No abstract available.

PMID:
28341143
16.

Acrolein, a New Villain in the Development of Alcoholic Liver Disease.

Seki E.

Cell Mol Gastroenterol Hepatol. 2016 Jul 26;2(5):544-545. doi: 10.1016/j.jcmgh.2016.06.005. eCollection 2016 Sep. No abstract available.

17.

LPS-TLR4 Pathway Mediates Ductular Cell Expansion in Alcoholic Hepatitis.

Odena G, Chen J, Lozano JJ, Altamirano J, Rodrigo-Torres D, Affo S, Morales-Ibanez O, Matsushita H, Zou J, Dumitru R, Caballeria J, Gines P, Arroyo V, You M, Rautou PE, Valla D, Crews F, Seki E, Sancho-Bru P, Bataller R.

Sci Rep. 2016 Oct 18;6:35610. doi: 10.1038/srep35610.

18.

Corrigendum to ''Cell-free protein synthesis system from Escherichia coli cells cultured at decreased temperatures improves productivity by decreasing DNA template degradation'' [Anal. Biochem. 377 (2008) 156-161].

Seki E, Matsuda N, Yokoyama S, Kigawa T.

Anal Biochem. 2017 Jan 15;517:22. doi: 10.1016/j.ab.2016.09.023. Epub 2016 Nov 2. No abstract available.

PMID:
27712971
19.

Radiographic changes and factors associated with subsequent progression of damage in weight-bearing joints of patients with rheumatoid arthritis under TNF-blocking therapies-three-year observational study.

Matsushita I, Motomura H, Seki E, Kimura T.

Mod Rheumatol. 2017 Jul;27(4):570-575. doi: 10.1080/14397595.2016.1227235. Epub 2016 Sep 26.

PMID:
27589926
20.

p62, Upregulated during Preneoplasia, Induces Hepatocellular Carcinogenesis by Maintaining Survival of Stressed HCC-Initiating Cells.

Umemura A, He F, Taniguchi K, Nakagawa H, Yamachika S, Font-Burgada J, Zhong Z, Subramaniam S, Raghunandan S, Duran A, Linares JF, Reina-Campos M, Umemura S, Valasek MA, Seki E, Yamaguchi K, Koike K, Itoh Y, Diaz-Meco MT, Moscat J, Karin M.

Cancer Cell. 2016 Jun 13;29(6):935-948. doi: 10.1016/j.ccell.2016.04.006. Epub 2016 May 19.

Supplemental Content

Support Center